A detailed history of Baxter Bros Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Baxter Bros Inc holds 1,927 shares of ABT stock, worth $218,521. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,927
Previous 2,027 4.93%
Holding current value
$218,521
Previous $210,000 4.29%
% of portfolio
0.03%
Previous 0.03%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 29, 2024

SELL
$100.07 - $118.13 $10,007 - $11,813
-100 Reduced 4.93%
1,927 $219,000
Q1 2024

Apr 26, 2024

SELL
$109.52 - $120.96 $98,677 - $108,984
-901 Reduced 30.77%
2,027 $230,000
Q4 2023

May 17, 2024

BUY
$90.19 - $110.4 $81,261 - $99,470
901 Added 44.45%
2,928 $322,000
Q3 2023

May 17, 2024

BUY
$95.53 - $114.62 $86,072 - $103,272
901 Added 44.45%
2,928 $283,000
Q3 2023

Oct 23, 2023

SELL
$95.53 - $114.62 $38,212 - $45,848
-400 Reduced 12.02%
2,928 $283,000
Q3 2022

Nov 10, 2022

SELL
$96.76 - $112.03 $5,708 - $6,609
-59 Reduced 1.74%
3,328 $322,000
Q2 2022

Jul 25, 2022

SELL
$102.07 - $123.37 $10,921 - $13,200
-107 Reduced 3.06%
3,387 $368,000
Q1 2022

Apr 20, 2022

SELL
$114.02 - $139.04 $37,854 - $46,161
-332 Reduced 8.68%
3,494 $414,000
Q2 2021

Aug 11, 2021

BUY
$105.79 - $124.53 $12,060 - $14,196
114 Added 3.07%
3,826 $444,000
Q4 2020

Jan 25, 2021

SELL
$105.0 - $114.42 $131,250 - $143,025
-1,250 Reduced 25.19%
3,712 $406,000
Q3 2020

Nov 05, 2020

SELL
$91.64 - $111.29 $18,328 - $22,258
-200 Reduced 3.87%
4,962 $540,000
Q2 2020

Jul 31, 2020

BUY
$76.57 - $98.0 $7,810 - $9,996
102 Added 2.02%
5,162 $472,000
Q1 2020

Apr 17, 2020

BUY
$62.82 - $91.86 $25,128 - $36,744
400 Added 8.58%
5,060 $399,000
Q4 2019

Jan 10, 2020

SELL
$78.51 - $87.4 $47,734 - $53,139
-608 Reduced 11.54%
4,660 $405,000
Q4 2019

Jan 09, 2020

BUY
$78.51 - $87.4 $24,102 - $26,831
307 Added 6.19%
5,268 $237,000
Q3 2019

Oct 21, 2019

BUY
$81.84 - $88.74 $32,736 - $35,496
400 Added 8.77%
4,961 $415,000
Q4 2018

Jan 22, 2019

SELL
$65.56 - $74.27 $28,977 - $32,827
-442 Reduced 8.83%
4,561 $330,000
Q3 2018

Oct 11, 2018

BUY
$60.81 - $73.36 $2,554 - $3,081
42 Added 0.85%
5,003 $367,000
Q2 2018

Jul 17, 2018

SELL
$57.57 - $63.54 $3,281 - $3,621
-57 Reduced 1.14%
4,961 $303,000
Q1 2018

May 16, 2018

BUY
$56.27 - $63.62 $15,192 - $17,177
270 Added 5.69%
5,018 $301,000
Q4 2017

Feb 01, 2018

SELL
$53.68 - $57.47 $14,654 - $15,689
-273 Reduced 5.44%
4,748 $271,000
Q3 2017

Oct 16, 2017

BUY
$48.06 - $53.64 $241,309 - $269,326
5,021
5,021 $268,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $199B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Baxter Bros Inc Portfolio

Follow Baxter Bros Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Baxter Bros Inc, based on Form 13F filings with the SEC.

News

Stay updated on Baxter Bros Inc with notifications on news.